Mind + Muscle

technical minds + legal muscle


dig deep

Patentability of Isolated DNA will be decided by the Supreme Court

  • 12.03.12
  • Robert W. Esmond, Ph.D. & Eric K. Steffe
  • Sterne, Kessler, Goldstein & Fox

On November 30, 2012, the U.S. Supreme Court agreed to review the Federal Circuit decision inAssociation for Molecular Pathology v. Myriad Genetics, holding that isolated human genes are patent-eligible under 35 U.S.C. § 101.  The question under review is whether human genes are patentable.  Download the PDF to review our client alert.


Related People

Related Services

Related Industries

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.